drugset / Trial / NCT00532571

Effects of Coenzyme Q10 in PSP and CBD

NCT00532571

Phase 2/3 Completed Lahey Clinic
RandomizedCrossoverDouble-blindTreatment

Summary

To compare the efficacy, safety and tolerability of Coenzyme Q 10 versus placebo in patients with atypical parkinsonian syndromes corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) ).

Timeline

Start
2004-01
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified